David Huntsman

17.9k total citations
28 papers, 1.4k citations indexed

About

David Huntsman is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, David Huntsman has authored 28 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in David Huntsman's work include Breast Cancer Treatment Studies (6 papers), HER2/EGFR in Cancer Research (5 papers) and Radiomics and Machine Learning in Medical Imaging (4 papers). David Huntsman is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), HER2/EGFR in Cancer Research (5 papers) and Radiomics and Machine Learning in Medical Imaging (4 papers). David Huntsman collaborates with scholars based in Canada, United States and United Kingdom. David Huntsman's co-authors include Andrew J. Coldman, Nikita Makretsov, Maggie C.U. Cheang, C. Blake Gilks, Stephen Chia, C. Blake Gilks, Karen A. Gelmon, Malcolm Hayes, Dianne Miller and Chris Bajdik and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

David Huntsman

28 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Huntsman Canada 17 681 567 377 295 177 28 1.4k
Nikita Makretsov Canada 14 593 0.9× 682 1.2× 380 1.0× 164 0.6× 195 1.1× 19 1.4k
Ann‐Marie Baker United Kingdom 17 630 0.9× 764 1.3× 404 1.1× 201 0.7× 133 0.8× 44 1.7k
Pierre Rudolph Germany 25 607 0.9× 621 1.1× 335 0.9× 323 1.1× 139 0.8× 41 1.5k
Bonnie L. King United States 19 605 0.9× 465 0.8× 361 1.0× 128 0.4× 206 1.2× 36 1.2k
Ossi R. Köchli Switzerland 10 861 1.3× 773 1.4× 552 1.5× 247 0.8× 195 1.1× 44 1.8k
Kim Wilber Switzerland 14 627 0.9× 787 1.4× 395 1.0× 224 0.8× 117 0.7× 16 1.5k
Esther M. de Kruijf Netherlands 18 724 1.1× 614 1.1× 363 1.0× 123 0.4× 114 0.6× 23 1.5k
Nicola Barnard United States 17 450 0.7× 481 0.8× 283 0.8× 185 0.6× 166 0.9× 40 1.1k
S M Edgerton United States 13 1.1k 1.6× 748 1.3× 661 1.8× 199 0.7× 262 1.5× 14 1.7k
Idris Tolgay Ocal United States 20 416 0.6× 345 0.6× 378 1.0× 259 0.9× 286 1.6× 53 1.5k

Countries citing papers authored by David Huntsman

Since Specialization
Citations

This map shows the geographic impact of David Huntsman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Huntsman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Huntsman more than expected).

Fields of papers citing papers by David Huntsman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Huntsman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Huntsman. The network helps show where David Huntsman may publish in the future.

Co-authorship network of co-authors of David Huntsman

This figure shows the co-authorship network connecting the top 25 collaborators of David Huntsman. A scholar is included among the top collaborators of David Huntsman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Huntsman. David Huntsman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bortolin, Laura, Daniel P. Salem, Daniel Gusenleitner, et al.. (2022). Extracellular vesicle-based biomarker assay for the detection of early-stage ovarian cancer.. Journal of Clinical Oncology. 40(16_suppl). 5542–5542. 1 indexed citations
2.
Farnell, David, David Huntsman, & Ali Bashashati. (2019). The coming 15 years in gynaecological pathology: digitisation, artificial intelligence, and new technologies. Histopathology. 76(1). 171–177. 9 indexed citations
3.
BenTaieb, Aïcha, Hector Li-Chang, David Huntsman, & Ghassan Hamarneh. (2017). A structured latent model for ovarian carcinoma subtyping from histopathology slides. Medical Image Analysis. 39. 194–205. 47 indexed citations
4.
Lim, Howard J., Yaoqing Shen, Janessa Laskin, et al.. (2014). The use of whole-genome sequencing in therapeutic for decision making in patients with advanced malignancies.. Journal of Clinical Oncology. 32(15_suppl). 11026–11026. 1 indexed citations
5.
Ali, Alaa M., Sarah‐Jane Dawson, Elena Provenzano, et al.. (2011). Comparison of methods for handling missing data on immunohistochemical markers in survival analysis of breast cancer. British Journal of Cancer. 104(4). 693–699. 55 indexed citations
6.
Carey, Mark, Roshan Agarwal, C. Blake Gilks, et al.. (2010). Functional Proteomic Analysis of Advanced Serous Ovarian Cancer Using Reverse Phase Protein Array: TGF-β Pathway Signaling Indicates Response to Primary Chemotherapy. Clinical Cancer Research. 16(10). 2852–2860. 45 indexed citations
7.
Ellard, Susan, Mark Clemons, Karen A. Gelmon, et al.. (2009). Randomized Phase II Study Comparing Two Schedules of Everolimus in Patients With Recurrent/Metastatic Breast Cancer: NCIC Clinical Trials Group IND.163. Journal of Clinical Oncology. 27(27). 4536–4541. 216 indexed citations
8.
Crabb, Simon J., Maggie C.U. Cheang, Samuel Leung, et al.. (2008). Basal Breast Cancer Molecular Subtype Predicts for Lower Incidence of Axillary Lymph Node Metastases in Primary Breast Cancer. Clinical Breast Cancer. 8(3). 249–256. 120 indexed citations
9.
Crabb, Simon J., Maggie C.U. Cheang, Samuel Leung, et al.. (2008). Basal Breast Cancer Molecular Subtype Predicts for Lower Incidence of Axillary Lymph Node Metastases in Primary Breast Cancer. 2(1). 28–35. 13 indexed citations
10.
Lynch, Henry T., Carlos Caldas, Debrah Wirtzfeld, et al.. (2007). Hereditary diffuse gastric cancer: Natural history, pathology, screening limitations, and prophylactic total gastrectomy in CDH1 mutation carriers. Journal of Clinical Oncology. 25(18_suppl). 4500–4500. 3 indexed citations
11.
Wiseman, Sam M., Hamid Masoudi, Dmitry Turbin, et al.. (2006). Derangement of the E-cadherin/catenin complex is involved in transformation of differentiated to anaplastic thyroid carcinoma. The American Journal of Surgery. 191(5). 581–587. 43 indexed citations
12.
Kelley, Todd W., David Huntsman, Kelly M. McNagny, Calvin D. Roskelley, & Eric D. Hsi. (2005). Podocalyxin : A Marker of Blasts in Acute Leukemia. American Journal of Clinical Pathology. 124(1). 134–142. 1 indexed citations
13.
Salamanca, Clara, et al.. (2005). Caspase-1α Is Down-regulated in Human Ovarian Cancer Cells and the Overexpression of Caspase-1α Induces Apoptosis. Cancer Research. 65(19). 8591–8596. 31 indexed citations
14.
So, Alan, et al.. (2005). Knockdown of the cytoprotective chaperone, clusterin, chemosensitizes human breast cancer cells bothin vitroandin vivo. Molecular Cancer Therapeutics. 4(12). 1837–1849. 76 indexed citations
15.
Au, Nicholas, A M Gown, Maggie C.U. Cheang, et al.. (2004). p63 Expression in Lung Carcinoma. Applied immunohistochemistry & molecular morphology. 12(3). 240–247. 134 indexed citations
16.
Alkushi, Abdulmohsen, Peter Lim, Andrew J. Coldman, et al.. (2004). Interpretation of p53 Immunoreactivity in Endometrial Carcinoma: Establishing a Clinically Relevant Cut-Off Level. International Journal of Gynecological Pathology. 23(2). 129–137. 91 indexed citations
17.
18.
Hicks, D., Marek Skacel, Erinn Downs‐Kelly, et al.. (2004). Invasive breast cancer clinical outcome is predicted by a novel bright-field assay for the simultaneous detection of HER2 gene amplification and protein expression (SILVERFISH). Journal of Clinical Oncology. 22(14_suppl). 667–667. 1 indexed citations
19.
Dai, Derek L., Nikita Makretsov, Eric I. Campos, et al.. (2003). Increased expression of integrin-linked kinase is correlated with melanoma progression and poor patient survival.. PubMed. 9(12). 4409–14. 103 indexed citations
20.
Makretsov, Nikita, C. Blake Gilks, Andrew J. Coldman, Malcolm Hayes, & David Huntsman. (2003). Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancer. Human Pathology. 34(10). 1001–1008. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nikita Makretsov Breakdown of academic impact, for papers by Ann‐Marie Baker Breakdown of academic impact, for papers by Pierre Rudolph Breakdown of academic impact, for papers by Bonnie L. King Breakdown of academic impact, for papers by Ossi R. Köchli Breakdown of academic impact, for papers by Kim Wilber Breakdown of academic impact, for papers by Esther M. de Kruijf Breakdown of academic impact, for papers by Nicola Barnard Breakdown of academic impact, for papers by S M Edgerton Breakdown of academic impact, for papers by Idris Tolgay Ocal
Rankless by CCL
2026